Published on:

Recall of Citalopram (Celexa) and Finasteride (Propecia) because Labels May Have Been Switched

The U.S. Food and Drug Administration (FDA) today announced that Greenstone LLC, a subsidiary of Pfizer Inc., recalled one lot of its depression medicine, Citalopram, and its prostate drug, Finasteride, because the wrong labels may have been put on the bottles. Bottles of Citalopram may contain Finasteride, used to treat prostate problems and baldness in men. Women who are pregnant or may become pregnant should not touch Finesteride, as it can be absorbed through the skin and can cause abnormalities to developing fetuses. The recall includes Citalopram 10 mg tablets in a 100-pill bottle and Finasteride 5 mg tablets in a 90-count bottle. Consumers can identify the recalled bottles because both have the lot number FI050058-A on the label. The FDA advises that if you have taken the wrong medication, you should immediately contact your doctor. Consumers should return any medicine with those lot numbers to their pharmacist. If you or a loved one is taking Celexa or Propecia and think you may have a mislabeled bottle, you may have a case. Contact the attorney team at Michael J. O’Connor and Associates for a free review of your case.